English

PENWEST PHARMACEUTICALS CO

EDGAR

Quarterly report (10-Q) · filed 2010-08-06

54 filing records in this dataset, filed from 1998-09-14 to 2010-08-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.6 million USD

2010-06-30 · USD

Exact inputs and evidence

Revenue: 13639000 USD Source

Operating margin

61.95%

2010-06-30 · %

Exact inputs and evidence

Operating Income: 8450000 USD Source
Revenue: 13639000 USD Source

Operating cash flow

4.11 million USD

2010-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 5533000 USD Source
Operating Cash Flow: 1427000 USD Source

Free cash flow

4.11 million USD

2010-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 5533000 USD Source
Operating Cash Flow: 1427000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 13.1 million USD 2010-06-30 Source
Exact value

13098000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

35.7 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Revenue: 6294000 USD · 2009-07-01 – 2009-09-30 Source
Revenue: 23812000 USD · 2009-01-01 – 2009-12-31 Source
Revenue: 16823000 USD · 2009-01-01 – 2009-09-30 Source
Revenue: 8758000 USD · 2010-01-01 – 2010-03-31 Source
Revenue: 13639000 USD · 2010-04-01 – 2010-06-30 Source

Net income

13.8 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Net income: 383000 USD · 2009-07-01 – 2009-09-30 Source
Net income: -1500000 USD · 2009-01-01 – 2009-12-31 Source
Net income: -2717000 USD · 2009-01-01 – 2009-09-30 Source
Net income: 3870000 USD · 2010-01-01 – 2010-03-31 Source
Net income: 8369000 USD · 2010-04-01 – 2010-06-30 Source

Operating cash flow

7.1 million USD

2009-07-01 – 2010-06-30

Exact inputs and evidence

Operating cash flow: -1272000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -1493000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: 74000 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: -1272000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: 1427000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 5533000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: 1427000 USD · 2010-01-01 – 2010-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-08-06.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2009-12-31
Operating income: 11 of 11 periods available· newest 2009-12-31
Net income: 11 of 11 periods available· newest 2009-12-31
Operating cash flow: 11 of 11 periods available· newest 2009-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2009-12-31
Total liabilities: 11 of 11 periods available· newest 2009-12-31
Current assets: 11 of 11 periods available· newest 2009-12-31
Current liabilities: 11 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+179%

Prior period

USD 8.53 million

2008-01-01 – 2008-12-31
Current period

USD 23.81 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

23812000 − 8534000 = 15278000 USD

8534000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
23812000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PENWEST PHARMACEUTICALS CO · 2009-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Year-over-year change in Revenue: 15278000 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 23812000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#18245 Input fundies:Revenue: 8534000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#18245
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 25.23 million

Prior period

−USD 26.73 million

2008-01-01 – 2008-12-31
Current period

−USD 1.5 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-1500000 − -26734000 = 25234000 USD

-26734000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-1500000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PENWEST PHARMACEUTICALS CO · 2009-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Year-over-year change in Net income: 25234000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1500000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#21999 Input fundies:NetIncome: -26734000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#21999
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 26.03 million

Prior period

−USD 25.96 million

2008-01-01 – 2008-12-31
Current period

USD 74,000

2009-01-01 – 2009-12-31

Exact inputs and evidence

74000 − -25958000 = 26032000 USD

-25958000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
74000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PENWEST PHARMACEUTICALS CO · 2009-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Year-over-year change in Operating cash flow: 26032000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 74000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#22729 Input fundies:OperatingCashFlow: -25958000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#22729
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 23.81 million 100% of revenue
Operating costs Derived USD 24.5 million 103% of revenue
Operating income −USD 686,000 −2.9% of revenue
Tax, interest and other Derived USD 814,000 3.4% of revenue
Net income −USD 1.5 million −6.3% of revenue

Cash

Operating cash flow USD 74,000 0.3% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 119% of revenue.
2001 Operating loss: operating costs were 393% of revenue.
2002 Operating loss: operating costs were 446% of revenue.
2003 Operating loss: operating costs were 665% of revenue.
2004 Operating loss: operating costs were 583% of revenue.
2005 Operating loss: operating costs were 500% of revenue.
2006 Operating loss: operating costs were 1,062% of revenue.
2007 Operating loss: operating costs were 1,162% of revenue.
2008 Operating loss: operating costs were 405% of revenue.
2009 Operating loss: operating costs were 103% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	42058000	50177000 Derived	-8119000	667000 Derived	-8786000	Unavailable	Source 2000-01-01 – 2000-12-31: 42058000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -8119000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -8786000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -7326000 USD Inspect Operating Cash Flow Open source
2001 2001-01-01 – 2001-12-31	5796000	22791000 Derived	-16995000	-1014000 Derived	-15981000	Unavailable	Source 2001-01-01 – 2001-12-31: 5796000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -16995000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -15981000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -11513000 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	5537000	24693000 Derived	-19156000	-2057000 Derived	-17099000	Unavailable	Source 2002-01-01 – 2002-12-31: 5537000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -19156000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -17099000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -14757000 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	4678000	31120000 Derived	-26442000	-10507000 Derived	-15935000	Unavailable	Source 2003-01-01 – 2003-12-31: 4678000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -26442000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -15935000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -22193000 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	5108000	29794000 Derived	-24686000	-901000 Derived	-23785000	Unavailable	Source 2004-01-01 – 2004-12-31: 5108000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -24686000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -23785000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -22887000 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	6213000	31083000 Derived	-24870000	-1972000 Derived	-22898000	Unavailable	Source 2005-01-01 – 2005-12-31: 6213000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -24870000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -22898000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -20061000 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	3499000	37163000 Derived	-33664000	-2352000 Derived	-31312000	Unavailable	Source 2006-01-01 – 2006-12-31: 3499000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -33664000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -31312000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -23643000 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	3308000	38426000 Derived	-35118000	-653000 Derived	-34465000	Unavailable	Source 2007-01-01 – 2007-12-31: 3308000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -35118000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -34465000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -29633000 USD Inspect Operating Cash Flow Open source
2008 2008-01-01 – 2008-12-31	8534000	34531000 Derived	-25997000	737000 Derived	-26734000	Unavailable	Source 2008-01-01 – 2008-12-31: 8534000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -25997000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -26734000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -25958000 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	23812000	24498000 Derived	-686000	814000 Derived	-1500000	Unavailable	Source 2009-01-01 – 2009-12-31: 23812000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -686000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -1500000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 74000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 23.8M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	42058000	Revenue: 42058000 Open source
20012001-12-31	Revenue	5796000	Revenue: 5796000 Open source
20022002-12-31	Revenue	5537000	Revenue: 5537000 Open source
20032003-12-31	Revenue	4678000	Revenue: 4678000 Open source
20042004-12-31	Revenue	5108000	Revenue: 5108000 Open source
20052005-12-31	Revenue	6213000	Revenue: 6213000 Open source
20062006-12-31	Revenue	3499000	Revenue: 3499000 Open source
20072007-12-31	Revenue	3308000	Revenue: 3308000 Open source
20082008-12-31	Revenue	8534000	Revenue: 8534000 Open source
20092009-12-31	Revenue	23812000	Revenue: 23812000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

179% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	12.7%	Revenue: 42058000 Open source Revenue: 37307000 Open source
20012001-12-31	Year over year	-86.2%	Revenue: 5796000 Open source Revenue: 42058000 Open source
20022002-12-31	Year over year	-4.5%	Revenue: 5537000 Open source Revenue: 5796000 Open source
20032003-12-31	Year over year	-15.5%	Revenue: 4678000 Open source Revenue: 5537000 Open source
20042004-12-31	Year over year	9.2%	Revenue: 5108000 Open source Revenue: 4678000 Open source
20052005-12-31	Year over year	21.6%	Revenue: 6213000 Open source Revenue: 5108000 Open source
20062006-12-31	Year over year	-43.7%	Revenue: 3499000 Open source Revenue: 6213000 Open source
20072007-12-31	Year over year	-5.5%	Revenue: 3308000 Open source Revenue: 3499000 Open source
20082008-12-31	Year over year	158%	Revenue: 8534000 Open source Revenue: 3308000 Open source
20092009-12-31	Year over year	179%	Revenue: 23812000 Open source Revenue: 8534000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2.9% 2009

Net margin -6.3% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	-19.3%	Operating Income: -8119000 Open source Revenue: 42058000 Open source
20012001-12-31	Operating margin	-293.2%	Operating Income: -16995000 Open source Revenue: 5796000 Open source
20022002-12-31	Operating margin	-346%	Operating Income: -19156000 Open source Revenue: 5537000 Open source
20032003-12-31	Operating margin	-565.2%	Operating Income: -26442000 Open source Revenue: 4678000 Open source
20042004-12-31	Operating margin	-483.3%	Operating Income: -24686000 Open source Revenue: 5108000 Open source
20052005-12-31	Operating margin	-400.3%	Operating Income: -24870000 Open source Revenue: 6213000 Open source
20062006-12-31	Operating margin	-962.1%	Operating Income: -33664000 Open source Revenue: 3499000 Open source
20072007-12-31	Operating margin	-1,061.6%	Operating Income: -35118000 Open source Revenue: 3308000 Open source
20082008-12-31	Operating margin	-304.6%	Operating Income: -25997000 Open source Revenue: 8534000 Open source
20092009-12-31	Operating margin	-2.9%	Operating Income: -686000 Open source Revenue: 23812000 Open source
20002000-12-31	Net margin	-20.9%	Net Income: -8786000 Open source Revenue: 42058000 Open source
20012001-12-31	Net margin	-275.7%	Net Income: -15981000 Open source Revenue: 5796000 Open source
20022002-12-31	Net margin	-308.8%	Net Income: -17099000 Open source Revenue: 5537000 Open source
20032003-12-31	Net margin	-340.6%	Net Income: -15935000 Open source Revenue: 4678000 Open source
20042004-12-31	Net margin	-465.6%	Net Income: -23785000 Open source Revenue: 5108000 Open source
20052005-12-31	Net margin	-368.5%	Net Income: -22898000 Open source Revenue: 6213000 Open source
20062006-12-31	Net margin	-894.9%	Net Income: -31312000 Open source Revenue: 3499000 Open source
20072007-12-31	Net margin	-1,041.9%	Net Income: -34465000 Open source Revenue: 3308000 Open source
20082008-12-31	Net margin	-313.3%	Net Income: -26734000 Open source Revenue: 8534000 Open source
20092009-12-31	Net margin	-6.3%	Net Income: -1500000 Open source Revenue: 23812000 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 42058000 Open source Operating Cash Flow: -7326000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 5796000 Open source Operating Cash Flow: -11513000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 5537000 Open source Operating Cash Flow: -14757000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 4678000 Open source Operating Cash Flow: -22193000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 5108000 Open source Operating Cash Flow: -22887000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 6213000 Open source Operating Cash Flow: -20061000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 3499000 Open source Operating Cash Flow: -23643000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 3308000 Open source Operating Cash Flow: -29633000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 8534000 Open source Operating Cash Flow: -25958000 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 23812000 Open source Operating Cash Flow: 74000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 74K 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	-7326000	Operating Cash Flow: -7326000 Open source
20012001-12-31	Operating cash flow	-11513000	Operating Cash Flow: -11513000 Open source
20022002-12-31	Operating cash flow	-14757000	Operating Cash Flow: -14757000 Open source
20032003-12-31	Operating cash flow	-22193000	Operating Cash Flow: -22193000 Open source
20042004-12-31	Operating cash flow	-22887000	Operating Cash Flow: -22887000 Open source
20052005-12-31	Operating cash flow	-20061000	Operating Cash Flow: -20061000 Open source
20062006-12-31	Operating cash flow	-23643000	Operating Cash Flow: -23643000 Open source
20072007-12-31	Operating cash flow	-29633000	Operating Cash Flow: -29633000 Open source
20082008-12-31	Operating cash flow	-25958000	Operating Cash Flow: -25958000 Open source
20092009-12-31	Operating cash flow	74000	Operating Cash Flow: 74000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7326000 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -11513000 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -14757000 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -22193000 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -22887000 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -20061000 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -23643000 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -29633000 Open source
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -25958000 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: 74000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

42% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Liabilities / assets	26.7%	Total Liabilities: 11277000 Open source Total Assets: 42294000 Open source
20012001-12-31	Liabilities / assets	23.5%	Total Liabilities: 13989000 Open source Total Assets: 59613000 Open source
20022002-12-31	Liabilities / assets	37.4%	Total Liabilities: 18797000 Open source Total Assets: 50220000 Open source
20032003-12-31	Liabilities / assets	13.8%	Total Liabilities: 10807000 Open source Total Assets: 78503000 Open source
20042004-12-31	Liabilities / assets	10%	Total Liabilities: 8721000 Open source Total Assets: 87522000 Open source
20052005-12-31	Liabilities / assets	9.9%	Total Liabilities: 6610000 Open source Total Assets: 67021000 Open source
20062006-12-31	Liabilities / assets	14.4%	Total Liabilities: 7621000 Open source Total Assets: 52742000 Open source
20072007-12-31	Liabilities / assets	56.1%	Total Liabilities: 20745000 Open source Total Assets: 36982000 Open source
20082008-12-31	Liabilities / assets	50%	Total Liabilities: 15928000 Open source Total Assets: 31854000 Open source
20092009-12-31	Liabilities / assets	42%	Total Liabilities: 10874000 Open source Total Assets: 25896000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.53× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	2.36×	Current Assets: 19299000 Open source Current Liabilities: 8170000 Open source
20012001-12-31	Current assets / current liabilities	3.53×	Current Assets: 37763000 Open source Current Liabilities: 10704000 Open source
20022002-12-31	Current assets / current liabilities	2.68×	Current Assets: 42011000 Open source Current Liabilities: 15656000 Open source
20032003-12-31	Current assets / current liabilities	8.97×	Current Assets: 68316000 Open source Current Liabilities: 7619000 Open source
20042004-12-31	Current assets / current liabilities	14.48×	Current Assets: 77282000 Open source Current Liabilities: 5336000 Open source
20052005-12-31	Current assets / current liabilities	16.08×	Current Assets: 57488000 Open source Current Liabilities: 3576000 Open source
20062006-12-31	Current assets / current liabilities	8.94×	Current Assets: 43069000 Open source Current Liabilities: 4815000 Open source
20072007-12-31	Current assets / current liabilities	3.23×	Current Assets: 25910000 Open source Current Liabilities: 8019000 Open source
20082008-12-31	Current assets / current liabilities	2.72×	Current Assets: 23391000 Open source Current Liabilities: 8599000 Open source
20092009-12-31	Current assets / current liabilities	2.53×	Current Assets: 19264000 Open source Current Liabilities: 7609000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 2000-01-01 – 2000-12-31	−USD 8.79 million Exact value Exact value: -8786000 USD 2000-01-01 – 2000-12-31: -8786000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2000-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -8786000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8786000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-03-002116.txt#8057 The citation records this snapshot. The page link may show a newer release later.	−USD 7.33 million Exact value Exact value: -7326000 USD 2000-01-01 – 2000-12-31: -7326000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2000-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -7326000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7326000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-03-002116.txt#8273 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 15.98 million Exact value Exact value: -15981000 USD 2001-01-01 – 2001-12-31: -15981000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2001-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -15981000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15981000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-04-001183.txt#8565 The citation records this snapshot. The page link may show a newer release later.	−USD 11.51 million Exact value Exact value: -11513000 USD 2001-01-01 – 2001-12-31: -11513000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2001-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -11513000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11513000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-04-001183.txt#8901 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 17.1 million Exact value Exact value: -17099000 USD 2002-01-01 – 2002-12-31: -17099000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2002-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -17099000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17099000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-05-001472.txt#9572 The citation records this snapshot. The page link may show a newer release later.	−USD 14.76 million Exact value Exact value: -14757000 USD 2002-01-01 – 2002-12-31: -14757000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2002-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -14757000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14757000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-05-001472.txt#9878 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 15.94 million Exact value Exact value: -15935000 USD 2003-01-01 – 2003-12-31: -15935000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2003-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -15935000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15935000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-06-001648.txt#9669 The citation records this snapshot. The page link may show a newer release later.	−USD 22.19 million Exact value Exact value: -22193000 USD 2003-01-01 – 2003-12-31: -22193000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2003-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -22193000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22193000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-06-001648.txt#9992 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 23.79 million Exact value Exact value: -23785000 USD 2004-01-01 – 2004-12-31: -23785000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2004-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -23785000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23785000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-07-001691.txt#19003 The citation records this snapshot. The page link may show a newer release later.	−USD 22.89 million Exact value Exact value: -22887000 USD 2004-01-01 – 2004-12-31: -22887000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2004-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -22887000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22887000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-07-001691.txt#19619 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 22.9 million Exact value Exact value: -22898000 USD 2005-01-01 – 2005-12-31: -22898000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2005-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -22898000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22898000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-08-001840.txt#22050 The citation records this snapshot. The page link may show a newer release later.	−USD 20.06 million Exact value Exact value: -20061000 USD 2005-01-01 – 2005-12-31: -20061000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2005-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -20061000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20061000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-08-001840.txt#22694 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 31.31 million Exact value Exact value: -31312000 USD 2006-01-01 – 2006-12-31: -31312000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2006-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -31312000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31312000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-09-001777.txt#20662 The citation records this snapshot. The page link may show a newer release later.	−USD 23.64 million Exact value Exact value: -23643000 USD 2006-01-01 – 2006-12-31: -23643000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2006-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -23643000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23643000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950135-09-001777.txt#21392 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 34.47 million Exact value Exact value: -34465000 USD 2007-01-01 – 2007-12-31: -34465000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2007-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -34465000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34465000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#21999 The citation records this snapshot. The page link may show a newer release later.	−USD 29.63 million Exact value Exact value: -29633000 USD 2007-01-01 – 2007-12-31: -29633000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2007-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -29633000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29633000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#22729 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 26.73 million Exact value Exact value: -26734000 USD 2008-01-01 – 2008-12-31: -26734000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2008-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -26734000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26734000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#21999 The citation records this snapshot. The page link may show a newer release later.	−USD 25.96 million Exact value Exact value: -25958000 USD 2008-01-01 – 2008-12-31: -25958000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2008-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: -25958000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25958000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#22729 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 1.5 million Exact value Exact value: -1500000 USD 2009-01-01 – 2009-12-31: -1500000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PENWEST PHARMACEUTICALS CO · 2009-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Net Income: -1500000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1500000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#21999 The citation records this snapshot. The page link may show a newer release later.	USD 74,000 Exact value Exact value: 74000 USD 2009-01-01 – 2009-12-31: 74000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PENWEST PHARMACEUTICALS CO · 2009-12-31 PENWEST PHARMACEUTICALS CO (edgar:1047188) Operating Cash Flow: 74000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:13:28Z Snapshot: 32a93e0e6bc83dab3ac02cb519b19223967ac06b47bd147971a9437d75fbf906 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1047188/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 74000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1047188/0000950123-10-025250.txt#22729 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

54 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001047188, 1047188, edgar:1047188

PENWEST PHARMACEUTICALS CO

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation